Charles Schwab’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-686,966
Closed -$1.01M 3587
2022
Q2
$1.01M Sell
686,966
-334,147
-33% -$491K ﹤0.01% 2795
2022
Q1
$1.18M Buy
1,021,113
+383,632
+60% +$441K ﹤0.01% 2789
2021
Q4
$1.59M Buy
637,481
+8,403
+1% +$21K ﹤0.01% 2772
2021
Q3
$3.22M Sell
629,078
-7,320
-1% -$37.5K ﹤0.01% 2580
2021
Q2
$5.29M Buy
636,398
+9,706
+2% +$80.7K ﹤0.01% 2320
2021
Q1
$5.46M Buy
626,692
+19,032
+3% +$166K ﹤0.01% 2255
2020
Q4
$6.6M Buy
607,660
+3,518
+0.6% +$38.2K ﹤0.01% 2085
2020
Q3
$7.21M Buy
604,142
+62,726
+12% +$748K ﹤0.01% 1878
2020
Q2
$8.7M Buy
541,416
+60,962
+13% +$979K ﹤0.01% 1725
2020
Q1
$7.45M Buy
480,454
+11,509
+2% +$179K ﹤0.01% 1623
2019
Q4
$11.5M Buy
468,945
+6,231
+1% +$153K 0.01% 1595
2019
Q3
$4.77M Buy
462,714
+3,406
+0.7% +$35.1K ﹤0.01% 1982
2019
Q2
$5.77M Buy
459,308
+77,012
+20% +$967K ﹤0.01% 1902
2019
Q1
$4.74M Buy
382,296
+50,746
+15% +$629K ﹤0.01% 1999
2018
Q4
$2.04M Buy
331,550
+55,974
+20% +$345K ﹤0.01% 2325
2018
Q3
$2.92M Sell
275,576
-128
-0% -$1.36K ﹤0.01% 2294
2018
Q2
$3.74M Buy
275,704
+11,693
+4% +$158K ﹤0.01% 2141
2018
Q1
$4.69M Buy
264,011
+18,255
+7% +$324K ﹤0.01% 1980
2017
Q4
$3.09M Buy
245,756
+28,588
+13% +$359K ﹤0.01% 2144
2017
Q3
$4.14M Buy
217,168
+64,721
+42% +$1.23M ﹤0.01% 1975
2017
Q2
$2.3M Sell
152,447
-9,199
-6% -$139K ﹤0.01% 2178
2017
Q1
$2.77M Buy
161,646
+32,650
+25% +$560K ﹤0.01% 2065
2016
Q4
$1.56M Buy
128,996
+6,468
+5% +$78.3K ﹤0.01% 2277
2016
Q3
$1.21M Sell
122,528
-4,774
-4% -$47K ﹤0.01% 2352
2016
Q2
$1.3M Buy
127,302
+2,250
+2% +$23K ﹤0.01% 2250
2016
Q1
$1.52M Buy
125,052
+44,948
+56% +$545K ﹤0.01% 2182
2015
Q4
$1.28M Buy
80,104
+2,436
+3% +$39K ﹤0.01% 2281
2015
Q3
$999K Buy
77,668
+4,334
+6% +$55.7K ﹤0.01% 2381
2015
Q2
$1.76M Buy
73,334
+34,879
+91% +$838K ﹤0.01% 2163
2015
Q1
$723K Buy
38,455
+1,916
+5% +$36K ﹤0.01% 2504
2014
Q4
$690K Buy
36,539
+8,328
+30% +$157K ﹤0.01% 2503
2014
Q3
$765K Buy
28,211
+556
+2% +$15.1K ﹤0.01% 2424
2014
Q2
$861K Buy
27,655
+10,224
+59% +$318K ﹤0.01% 2388
2014
Q1
$397K Buy
17,431
+4,605
+36% +$105K ﹤0.01% 2689
2013
Q4
$267K Buy
12,826
+432
+3% +$8.99K ﹤0.01% 2857
2013
Q3
$511K Buy
12,394
+582
+5% +$24K ﹤0.01% 2540
2013
Q2
$354K Buy
+11,812
New +$354K ﹤0.01% 2664